Combined effects of marijuana and nicotine on memory performance and hippocampal volume

Behavioural Brain Research

Volumn 293, Issue , 2015, Pages 46-53

  Filbey, Francesca M ^a   McQueeny, Tim ^a   Kadamangudi, Shrinath ^a   Bice, Collette ^a   Ketcherside, Ariel ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cannabis; Comorbid substance use; Hippocampus; Morphometry; Nicotine

Indexed keywords

CANNABIS; NICOTINE; DRUG COMBINATION;

ADULT; ALCOHOL CONSUMPTION; ANATOMICAL VARIATION; ARTICLE; BRAIN FUNCTION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MEMORY; MORPHOMETRICS; NEUROANATOMY; PRIORITY JOURNAL; RECALL; SMOKING; SOCIAL BEHAVIOR; SUBSTANCE USE; ADOLESCENT; CANNABIS SMOKING; COGNITION; DRUG COMBINATION; DRUG EFFECTS; LEARNING; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CANNABIS; COGNITION; DRUG COMBINATIONS; FEMALE; HIPPOCAMPUS; HUMANS; LEARNING; MALE; MARIJUANA SMOKING; MEMORY; NICOTINE; SMOKING; YOUNG ADULT;

EID: 84938125283     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.07.029     Document Type: Article

References (53)

1. Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, in NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. 2013, Substance Abuse and Mental Health Services Administration: Rockville, MD.
2. Atha M., Blanchard S. Regular Users: Self-reported Drug Consumption Patterns and Attitudes to Drugs Among 1333 Regular Cannabis Users 1997, IDMU Publications, Independent Drug Monitoring Unit, Wigan, England.
3. Bennett A. Cannabis: a harm reduction perspective. A Cannabis Reader: Global Issues and Local Experiences, Monograph Series 8 2008, 171-183. European Monitoring Centre for Drugs and Drug Addiction, Lisbon. S.R. Sznitman, B. Olsson, R. Room (Eds.).
4. Ashtari M., et al. Medial temporal structures and memory functions in adolescents with heavy cannabis use. J. Psychiatr. Res. 2011, 45(8):1055-1066.
5. Demirakca T., et al. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend 2011, 2-3:242-245.
6. Matochik J.A., et al. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 2005, 77(1):23-30.
7. Wilson W., et al. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J. Addict. Dis. 2000, 19(1):1-22.
8. Yucel M., et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry 2008, 65(6):694-701.
9. Lorenzetti V., et al. Structural MRI. findings in long-term cannabis users: what do we know?. Subst. Use Misuse 2010, 45(11):1787-1808.
10. Chan G.C., et al. Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J. Neurosci. 1998, 18(14):5322-5332.
11. Cousijn J., et al. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 2012, 59(4):3845-3851.
12. Smith M.J., Cobia D.J., Reilly J.L., Gilman J.M., Roberts A.G., et al. Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects. Hippocampus 2015, (March 11).
13. Yu R., Zhao Lu L.L. Regional grey and white matter changes in heavy male smokers. PLoS One 2011, 6(11):e27440.
14. Brody A.L., et al. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol. Psychiatry 2004, 55(1):77-84.
15. Liao Y., et al. Differences between smokers and non-smokers in regional gray matter volumes: a voxel-based morphometry study. Addict. Biol. 2012, 17(6):977-980.
16. Trauth J.A., Seidler F.J., Slotkin T.A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res. 2000, 867(1-2):29-39.
17. Chen W.J., et al. Long-term nicotine exposure reduces Purkinje cell number in the adult rat cerebellar vermis. Neurotoxicol. Teratol. 2003, 25(3):329-334.
18. Jacobsen L.K., et al. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol. Psychiatry 2007, 61(1):31-40.
19. Musso F., et al. Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology (Berl.) 2007, 191(1):159-169.
20. Tait R.J., Mackinnon A., Christensen H. Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction 2011, 106(12):2195-2203.
21. Ehrenreich H., et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl.) 1999, 142(3):295-301.
22. Hanson K.L., et al. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict. Behav. 2010, 35(11):970-976.
23. Egerton A., et al. Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neurosci. Biobehav. Rev. 2006, 30(5):680-695.
24. Morgan C.J., et al. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol. Med. 2012, 42(2):391-400.
25. Gonzalez R., et al. Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J. Clin. Exp. Neuropsychol. 2012, 34(9):962-976.
26. Harvey M.A., et al. The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev. 2007, 26(3):309-319.
27. Fried P.A., Watkinson B., Gray R. Neurocognitive consequences of marihuana-a comparison with pre-drug performance. Neurotoxicol. Teratol. 2005, 27(2):231-239.
28. Viveros M.P., Marco E.M., File S.E. Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci. Biobehav. Rev. 2006, 30(8):1161-1181.
29. Gonzalez S., et al. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res. 2002, 954(1):73-81.
30. Oz M., et al. Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. J. Pharmacol. Exp. Ther. 2004, 310(3):1152-1160.
31. Valjent E., et al. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br. J. Pharmacol. 2002, 135(2):564-578.
32. Filbey F.M., et al. Marijuana craving in the brain. Proc. Natl. Acad. Sci. U. S. A. 2009, 13:16-21.
33. Wechsler D. Manual for the Wechsler Abbreviated Scale of Intelligence 1999, The Psychological Corporation, San Antonio, TX.
34. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
35. Beck A.T., Steer R.A. Beck Anxiety Inventory Manual 1993, Harcourt Brace and Company, San Antonio, TX, USA.
36. Barkley R., Murphy K.R. Attention-Deficit Hyperactivity Disorder: A Clinical Workbook 1998, The Guilford Press, New York, NY. 2nd ed.
37. First M.B., et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
38. Sobell L.C., Sobell M.B. Timeline follow-back: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods 1992, 41-72. Humana Press, Totowa, NJ, USA. R.Z. Litten, J.P. Allen (Eds.).
39. Wechsler D. Wechsler Memory Scale 1997, The Psychological Corporation, San Antonio, TX. Third Edition.
40. Fischl B., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
41. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 2008, 1(1):81-98.
42. Batalla A., et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One 2013, 8(2):e55821.
43. Rubino T., et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 2009, 19(8):763-772.
44. Rubino T., Zamberletti E., Parolaro D. Adolescent exposure to cannabis as a risk factor for psychiatric disorders. J. Psychopharmacol. 2012, 26(1):177-188.
45. Landfield P.W., Cadwallader L.B., Vinsant S. Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Res. 1988, 443(1-2):47-62.
46. Gray R., et al. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996, 383(6602):713-716.
47. Hayase T. Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. BMC Neurosci. 2013, 14:20.
48. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl.) 1998, 138(3-4):217-230.
49. Mansvelder H.D., et al. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berl.) 2006, 184(3-4):292-305.
50. Siemens A.J., Kalant H. Metabolism of delta-1-tetrahydrocannabinol by the rat in vivo and in vitro. Biochem. Pharmacol. 1975, 24(7):755-762.
51. Benowitz N.L., et al. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther. 1988, 44(1):23-28.
52. Heishman S.J., Kleykamp B.A., Singleton E.G. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl.) 2010, 210(4):453-469.
53. Viveros M.P., et al. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav. Pharmacol. 2005, 16(5-6):353-362.